Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain
1 other identifier
interventional
20
1 country
1
Brief Summary
To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-pain
Started Feb 2014
Typical duration for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 16, 2014
CompletedFirst Posted
Study publicly available on registry
April 21, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedOctober 1, 2024
September 1, 2024
2.8 years
April 16, 2014
September 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Brief Pain Inventory Questionnaire
To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.
4 weeks
SF-12 Health Survey Scoring Demonstration
4 weeks
Secondary Outcomes (1)
SF-12 Health Survey Scoring Demonstration and Brief Pain Inventory Score
2 weeks, 4 weeks, 6 months
Study Arms (1)
MBS therapy education
EXPERIMENTALInterventions
A one-on-one interview with the patient and the principal investigator and group educational sessions.
Eligibility Criteria
You may qualify if:
- Adult patient 18 \> years old
- Chronic pain without clear organic etiology after full evaluation by primary care physician or subspecialist
- Pain persistent for a minimum of 3 days a week for the past three months prior to enrollment
You may not qualify if:
- Patients \< 18 years of age
- Diagnosed organic disease as cause of pain, such as but not limited to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis)
- Pregnancy
- Severe depression or recent suicide attempt
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael W Donnino, MD
Beth Israel Deaconess Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Michael W. Donnino, MA
Study Record Dates
First Submitted
April 16, 2014
First Posted
April 21, 2014
Study Start
February 1, 2014
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
October 1, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share